National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Send to Printer
Nasopharyngeal Cancer Treatment (PDQ®)     
Last Modified: 12/14/2007
Health Professional Version
Stage I Nasopharyngeal Cancer

Current Clinical Trials

Standard treatment options:

  • High-dose radiation therapy to the primary tumor site and prophylactic radiation therapy to the nodal drainage.[1-3]
Current Clinical Trials

Check for U.S. clinical trials from NCI's PDQ Cancer Clinical Trials Registry that are now accepting patients with stage I nasopharyngeal cancer 1. The list of clinical trials can be further narrowed by location, drug, intervention, and other criteria.

General information about clinical trials is also available from the NCI Web site 2.

References

  1. Mesic JB, Fletcher GH, Goepfert H: Megavoltage irradiation of epithelial tumors of the nasopharynx. Int J Radiat Oncol Biol Phys 7 (4): 447-53, 1981.  [PUBMED Abstract]

  2. Hoppe RT, Goffinet DR, Bagshaw MA: Carcinoma of the nasopharynx. Eighteen years' experience with megavoltage radiation therapy. Cancer 37 (6): 2605-12, 1976.  [PUBMED Abstract]

  3. Mendenhall WM, Riggs CE Jr, Cassisi NJ: Treatment of head and neck cancers. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds.: Cancer: Principles and Practice of Oncology. 7th ed. Philadelphia, Pa: Lippincott Williams & Wilkins, 2005, pp 662-732. 



Table of Links

1http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?diagnosis=38905&tt=1&a
mp;format=2&cn=1
2http://www.cancer.gov/clinicaltrials